US2013041035A1PendingUtilityA1
Topical application of adapalene for the long-term treatment of acne vulgaris
Est. expiryJan 26, 2025(expired)· nominal 20-yr term from priority
Inventors:Michael Graeber
A61P 29/00A61P 17/10A61P 17/00A61K 31/192
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Administration of adapalene in a topical medicament to a patient so as to sustain its biological response in the treatment of acne vulgaris, wherein the administration pattern of the topical medicament comprises topically applying onto the afflicted skin area a therapeutically effective amount of adapalene at least once every two days for at least 6 months.
Claims
exact text as granted — not AI-modified1 . A regimen for the treatment of acne vulgaris, comprising topically applying onto the afflicted skin area of an individual in need of such treatment, an effective amount of a topical adapalene formulation at least once every two days for a period of time of at least six months, said topical adapalene formulation comprising 0.3% adapalene by weight.
2 . The regimen for the treatment of acne vulgaris as defined by claim 1 , said topical adapalene formulation comprising an aqueous gel composition.
3 . The regimen for the treatment of acne vulgaris as defined by claim 1 , comprising topically applying said adapalene formulation once daily onto said afflicted skin area.
4 . The regimen for the treatment of acne vulgaris as defined by claim 3 , comprising topically applying said adapalene formulation once daily, in the evening after wash, onto said afflicted skin area.
5 . The regimen for the treatment of acne vulgaris as defined by claim 1 , comprising topically applying said adapalene formulation onto said afflicted skin area for at least nine months.
6 . The regimen for the treatment of acne vulgaris as defined by claim 1 , comprising topically applying said adapalene formulation onto said afflicted skin area for at least twelve months.
7 . The regimen for the treatment of acne vulgaris as defined by claim 2 , comprising topically applying said aqueous adapalene gel composition onto said afflicted skin area for at least nine months.
8 . The regimen for the treatment of acne vulgaris as defined by claim 2 , comprising topically applying said aqueous adapalene gel composition onto said afflicted skin area for at least twelve months.
9 . The regimen for the treatment of acne vulgaris as defined by claim 1 , said afflicted skin area containing 20 to 100 non-inflammatory lesions, 20 to 50 inflammatory lesions, and no active nodules or cysts.
10 . The regimen for the treatment of acne vulgaris as defined by claim 2 , said afflicted skin area containing 20 to 100 non-inflammatory lesions, 20 to 50 inflammatory lesions, and no nodules or cysts.Join the waitlist — get patent alerts
Track US2013041035A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.